Inventor · disambiguated record
Maja Janas
Also filed as: JANAS MAJA
5 granted patents·5 pending applications·27 citations·filing 2017–2025
75Inventor score
Technology areasC12N
Files withALNYLAM PHARMACEUTICALS INC10
Top patents by PatentIndex Score
10 records- 0196US11504391B1Modified RNA agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Nov 22, 2022·18 cites·42 claims
- 0294US10995336B2Serpina1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted May 4, 2021·8 cites·41 claims
- 0388US11725207B2Serpina1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Aug 15, 2023·1 cites·123 claims
- 0485US2025207131A1Modified rna agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0583US2025043279A1SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0679US12275938B2Modified RNA agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 15, 2025·0 cites·38 claims
- 0776US2023256001A1Modified rna agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0872US12247203B2Modified RNA agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Mar 11, 2025·0 cites·20 claims
- 0969US2025205272A1Modified rna agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1052US2023016929A1Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maja Janas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →